ReCap Total Hip Resurfacing Prospective Data Collection

This study is currently recruiting participants.

Verified by Biomet, Inc., June 2009

First Received: September 23, 2008 Last Updated: June 18, 2009 History of Changes

Sponsor:	Biomet, Inc.
Information provided by:	Biomet, Inc.
ClinicalTrials.gov Identifier:	NCT00758472

Purpose

Prospective data collection on survivorship of ReCap Total Hip Resurfacing

Condition	Intervention
Total Hip Resurfacing	Device: ReCap Total Hip Resurfacing

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	ReCap Total Hip Resurfacing Prospective Data Collection

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	500
Study Start Date:	March 2005
Estimated Study Completion Date:	March 2020
Estimated Primary Completion Date:	March 2020 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
1	Device: ReCap Total Hip Resurfacing ReCap Total Hip Resurfacing

Eligibility

Study Population

Patients suitable for Total Hip Resurfacing

Criteria

Inclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00758472

Locations

United Kingdom
Robert Jones & Agnes Hunt Orthopaedic & District Hospital NHS Trust	Recruiting
Oswestry, United Kingdom
Contact: S Karlakki, FRCS 01691 404000
Southmead Hospital	Recruiting
Bristol, United Kingdom
Contact: E J Smith, FRCS 0117 950 5050

Sponsors and Collaborators

Biomet, Inc.

More Information

No publications provided

Responsible Party:	Biomet UK ( David Stephenson )
Study ID Numbers:	BMET UK 08
Study First Received:	September 23, 2008
Last Updated:	June 18, 2009
ClinicalTrials.gov Identifier:	NCT00758472 History of Changes
Health Authority:	United Kingdom: Medicines and Healthcare Products Regulatory Agency

ClinicalTrials.gov processed this record on February 08, 2010